Table 4 The association between FAR and clinicopathological features in patients with NSCLC
Clinicopathological variables | No. of studies | No. of patients | Effects model | OR (95%CI) | p | Heterogeneity I2(%) Ph | |
|---|---|---|---|---|---|---|---|
Gender (male vs. female) | 3 | 724 | Fixed | 1.53(1.12–2.08) | 0.008 | 25.2 | 0.263 |
Smoking history (yes vs. no) | 3 | 724 | Random | 1.44(0.80–2.59) | 0.218 | 72.4 | 0.027 |
ECOG PS (≥ 1 vs. 0) | 2 | 464 | Random | 1.60(0.74–3.45) | 0.230 | 66.0 | 0.086 |
Tumor size (cm) (≥ 5 vs. < 5) | 2 | 530 | Fixed | 1.52(1.08–2.14) | 0.017 | 31.7 | 0.226 |